NEW YORK CITY, NY / ACCESS Newswire / August 4, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Molina Healthcare, Inc. ("Molina" or "the Company") (NYSE:MOH). Investors who purchased Molina securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/MOH. […]

NEW YORK, NY / ACCESS Newswire / August 4, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dow Inc. ("Dow" or "the Company") (NYSE:DOW). Investors who purchased Dow securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/DOW. Investigation Details

NEW YORK, NY / ACCESS Newswire / August 4, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Telix Pharmaceuticals Limited ("Telix" or "the Company") (NASDAQ:TLX). Investors who purchased Telix securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/TLX. Investigation

NEW YORK CITY, NY / ACCESS Newswire / August 4, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lockheed Martin Corporation ("Lockheed" or "the Company") (NYSE:LMT). Investors who purchased Lockheed securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/LMT.

NEW YORK CITY, NY / ACCESS Newswire / August 4, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Replimune Group, Inc. ("Replimune" or "the Company") (NASDAQ:REPL). Investors who purchased Replimune securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/REPL.

NEW YORK CITY, NY / ACCESS Newswire / August 4, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Geely Automobile Holdings Limited ("Geely" or "the Company") (OTCMKTS:GELYF)(OTCMKTS:GELYY). Investors who purchased Geely securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site:

NEW YORK CITY, NY / ACCESS Newswire / August 4, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Geely Automobile Holdings Limited ("Geely" or "the Company") (OTCMKTS:GELYF; GELYY). Investors who purchased Geely securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s

NEW YORK CITY, NY / ACCESS Newswire / August 4, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ZEEKR Intelligent Technology Holding Limited ("Zeekr" or "the Company") (NASDAQ:ZK). Investors who purchased Zeekr securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s

HealthBook+, a leader in AI-powered digital health, announces its support for the Making Health Technology Great Again initiative and highlights how it has already brought this vision to life. Since April 2025,HealthBook+ has enabled thousands of consumers and clinicians to benefit from its platform, which unifies health records, empowers patients with evidence-based lifestyle techniques, and

NEW YORK CITY, NY / ACCESS Newswire / August 4, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GSK plc ("GSK" or "the Company") (NYSE:GSK). Investors who purchased GSK securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/GSK. Investigation